ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664214 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664214; 2) Community: the network communities that were significantly associated with the response to NSC 664214; 3) Molecule: the relationships between components within communities and NSC 664214; 4) MDR: the compounds that were significantly associated with the NSC 664214.

NSC Compound Enrichment Correlation
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0480633950058475 -0.014986965
NSC 743532 Null 0.0480633950058475 -0.073940621
NSC 750050 Null 0.0480633950058475 0.23799767
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0480633950058475 0.14508665
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0480633950058475 0.25292391
NSC 755442 Null 0.0480633950058475 -0.12166587
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.0480633950058475 0.049757572
NSC 81280 Null 0.0480633950058475 0.092458145
NSC 9594 Safranin bluish 0.0480633950058475 0.45378355
NSC 728323 16-[3-Methoxy-4-(2-pyrrolidine-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 2.29407746864232e-005 0.4394272
Total:97  Current:96    [First] [Prev] [Next] [Last]